Clinical Trials Browser

Interventional × Fecal Microbiota Transplantation × Dermatologic × Clear all

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Phase 1 Recruiting

BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT06206707 2025-11-17

Immunobiome

Phase NA Recruiting

DermatologicGenitourinary

Colitis, Diarrhea, Kidney Neoplasms, Melanoma

NCT05286294 2025-07-03

MITRIC

Phase 2 Active not recruiting

DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT05251389 2025-03-10

FMT to Convert Response to Immunotherapy

Phase 1/2 Recruiting

Melanoma

NCT03341143 2024-10-30

Fecal Microbiota Transplant (FMT) in Melanoma Patients

Phase 2 Completed

20 enrolled 19 charts

Melanoma

NCT04951583 2024-08-07

FMT-LUMINATE

Phase 2 Active not recruiting

DermatologicThoracic

Non Small Cell Lung Cancer Metastatic

NCT03353402 2019-04-03

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

Phase 1 Unknown

Melanoma